CXCL9: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| (One intermediate revision by the same user not shown) | |||
| Line 30: | Line 30: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 06:04, 17 March 2025
CXCL9 is a small cytokine belonging to the CXC chemokine family that is also known as Monokine induced by gamma interferon (MIG). It is secreted by activated monocytes and neutrophils and expressed in a variety of tissues. CXCL9 functions as a chemoattractant for T cells and dendritic cells by interacting with the chemokine receptor CXCR3.
Structure[edit]
CXCL9 is a 125-amino acid protein with a four-cysteine motif common to CXC chemokines. The protein structure includes a triple-stranded antiparallel beta-sheet and a C-terminal alpha-helix.
Function[edit]
CXCL9 is secreted by cells in response to IFN-gamma, and it attracts T cells and promotes T cell adhesion and migration. It is also involved in angiostasis, a process that limits the growth of new blood vessels.
Clinical significance[edit]
CXCL9 has been associated with several diseases, including autoimmune diseases, cancer, and infectious diseases. It is often upregulated in these conditions, suggesting a role in the immune response.


